IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System

Hepatic inflammation and fibrosis: Functional links and key pathways

(2015) Ekihiro Seki et al.   HEPATOLOGY

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease

(2015) Mohammed Eslam et al.   Nature Communications

Transcriptional Regulation ofIFN-λ Genes in Hepatitis C Virus-infected Hepatocytes via IRF-3·IRF-7·NF-κB Complex

(2014) Hai-Chon Lee et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome

(2014) Eric G. Meissner et al.   JOURNAL OF CLINICAL INVESTIGATION

Persistent Hepatitis C Virus Infection Impairs Ribavirin Antiviral Activity through Clathrin-Mediated Trafficking of Equilibrative Nucleoside Transporter 1

(2014) Rajesh Panigrahi et al.   JOURNAL OF VIROLOGY

Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis

(2014) Partha K. Chandra et al.   PLoS One

HCV Infection Selectively Impairs Type I but Not Type III IFN Signaling

(2013) Partha K. Chandra et al.   AMERICAN JOURNAL OF PATHOLOGY

Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells

(2013) Kyoungsub Song et al.   HEPATOLOGY

Role ofIL28Bfor chronic hepatitis C treatment toward personalized medicine

(2013) Kentaro Matsuura et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

IFNL4-ΔG Genotype Is Associated With Slower Viral Clearance in Hepatitis C, Genotype-1 Patients Treated With Sofosbuvir and Ribavirin

(2013) Eric G. Meissner et al.   JOURNAL OF INFECTIOUS DISEASES

Interferon free therapy with direct acting antivirals for HCV

(2013) Tarik Asselah et al.   LIVER INTERNATIONAL

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

(2013) Ludmila Prokunina-Olsson et al.   NATURE GENETICS

Epidemiology and natural history of HCV infection

(2013) Behzad Hajarizadeh et al.   Nature Reviews Gastroenterology & Hepatology

Current and Future Therapies for Hepatitis C Virus Infection

(2013) T. Jake Liang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C

(2013) T.-H. Su et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effect of IL28B Genotype on Early Viral Kinetics During Interferon-Free Treatment of Patients With Chronic Hepatitis C

(2012) Tom W. Chu et al.   GASTROENTEROLOGY

Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver

(2012) Shu-hao Hsu et al.   JOURNAL OF CLINICAL INVESTIGATION

Type III Interferons, IL-28 and IL-29, Are Increased in Chronic HCV Infection and Induce Myeloid Dendritic Cell-Mediated FoxP3+ Regulatory T Cells

(2012) Angela Dolganiuc et al.   PLoS One

An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis

(2011) Maria Hatziapostolou et al.   CELL

Interferon-β and interferon-λ signaling is not affected by interferon-induced refractoriness to interferon-α in vivo

(2011) Zuzanna Makowska et al.   HEPATOLOGY

Positive regulation of hepatic miR-122 expression by HNF4α

(2011) Zhen-Ya Li et al.   JOURNAL OF HEPATOLOGY

USP18-Based Negative Feedback Control Is Induced by Type I and Type III Interferons and Specifically Inactivates Interferon α Response

(2011) Véronique François-Newton et al.   PLoS One

Interferon-lambda and therapy for chronic hepatitis C virus infection

(2011) Raymond P. Donnelly et al.   TRENDS IN IMMUNOLOGY

Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1

(2011) Sibnarayan Datta et al.   Virology Journal

IFN-α and IFN-λ differ in their antiproliferative effects and duration of JAK/STAT signaling activity

(2010) Stephen G. Maher et al.   CANCER BIOLOGY & THERAPY

IL28B-Genotype Testing Now and in the Era of Direct-Acting Antiviral Agents

(2010) Timothy R. Morgan et al.   Clinical Gastroenterology and Hepatology

Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study

(2010) Andri Rauch et al.   GASTROENTEROLOGY

A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma

(2010) Chunxian Zeng et al.   HEPATOLOGY

Induction and Evasion of Innate Antiviral Responses by Hepatitis C Virus

(2010) Stanley M. Lemon   JOURNAL OF BIOLOGICAL CHEMISTRY

IL28B inhibits hepatitis C virus replication through the JAK–STAT pathway

(2010) Leiliang Zhang et al.   JOURNAL OF HEPATOLOGY

Hepatocellular carcinoma: a global view

(2010) Ju Dong Yang et al.   Nature Reviews Gastroenterology & Hepatology

Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway

(2010) Sidhartha Hazari et al.   Virology Journal

Activation of Protein Kinase Cη by Type I Interferons

(2009) Amanda J. Redig et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The global burden of hepatitis C

(2009) Daniel Lavanchy   LIVER INTERNATIONAL

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

(2009) David L. Thomas et al.   NATURE

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

(2009) Vijayaprakash Suppiah et al.   NATURE GENETICS

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

(2009) Yasuhito Tanaka et al.   NATURE GENETICS

Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection

(2009) R. E. Lanford et al.   SCIENCE